Viruses: are they alive? – KCW London – Kensington Chelsea & Westminster Today

Sometimes, it can help to think about a topic from an objective, scientific point of view. This can help to ease anxieties surrounding the subject. With all the overwhelming influx of news centering around one subject lately, lets take a moment to get away from Covid-19, and think about a virus and its relationship to life from a scientific perspective.

Is a virus alive? In order to answer this question, we must first think about life. What is life? What does life need, and what defines something as living? Heres an interesting fact: there is no general accepted definition of life.

There are countless lenses to explore the question of what is alive: physiological, metabolic, biochemical, molecular and genetic, to name a few. Yet, with all of these subdisciplines of biological sciences, there is no generally accepted definition of life. Yes, there are vast collections based on years of research and studies on all kinds of organisms; there are hundreds of thousands of different ways to understand how life has evolved in the past 3.5 billion years. Yet with all of this data, we cant even agree on one thing: what makes something living?

The more we explore our own world and the worlds around us, both within and beyond our solar system, the definition of living is stretched further beyond our conception. Living things generally need to be made up of one or more cells (have an inside and an outside), have a metabolism, or use energy to carry out functions. An organism must be able to maintain its internal environment, grow, reproduce, respond to external stimuli, and excrete waste. Simple, no? Even with such a simplistic list, there are exceptions. For example, mules cannot reproduce, but they are indeed alive!

Viruses used to be thought of as the simplest form of all gene-bearing life forms. In 1935, Wendell M. Stanley & colleagues at NYU crystallized a virus (tobacco mosaic virus) for the first time. The scientists saw that the virus consisted of a package of complex biochemicals and nucleic acids (DNA or RNA) enclosed in a protein coat that may also contain viral proteins involved in infection. Viruses lack the essential systems necessary for metabolic functions, the biochemical activity of life. Based on this, a virus seemed to be more like a chemistry set than an organism.

Everything changes when a virus enters a cell. It becomes very active, and starts to self-replicate; a widely agreed upon function of life. Heres the thing: Viruses are only self-replicating and environment-altering when they enter a host, therefore they must rely on the host. Living organisms are thought to require a degree of biochemical autonomy, meaning they are able to carry on the metabolic activities that produce the molecules and energy needed to sustain themselves without another organisms help. A bacterium, for example, is considered alive because although it consists of a single cell, it is able to generate energy and the molecules needed to sustain itself and can reproduce, unlike a virus.

Each biological speciality tends to define life on its own terms. If were going by, say, a physiological definition, aliens visiting from another planet might very well believe that automobiles are alive! Vehicles can be considered to consume, metabolize, excrete, breathe, move and respond to external stimuli. With this line of thinking, cars could even be considered the dominant life form on the planet due to how landscapes have been designed for their benefit.

Viruses can be seen as being on the border between chemistry and life. So, its ultimately up to you: what makes something alive?

More:
Viruses: are they alive? - KCW London - Kensington Chelsea & Westminster Today

ELITechGroup MDx LLC and OSANG Healthcare Join Fight Against COVID-19 in the United States Providing FDA Emergency Use Authorization Rapid Detection…

BOTHELL, Wash., April 20, 2020 /PRNewswire/ --ELITechGroup MDx LLC, a leading global provider of diagnostic testing products, and its Korean partner, OSANG Healthcare, announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its SARS-CoV-2 virus test for use in the United States.

The GeneFinderTM COVID-19 Plus RealAmp Kit provides a fast and easy-to-use diagnostic solution to rapidly identify clusters of infection and has been validated using the ABI 7500 thermocycler and Bio-Rad CFX96 cycler both popular Polymerase Chain Reaction(PCR) instruments found in diagnostics laboratories throughout the country.

Delivering qualitative results within hours, the highly sensitive testing kit requires a single tube rather than multiple reactions and uses Aveolar fluid, throat swab or sputum samples in a PCR instrument to detect the virus.

"The dramatic explosion of the novel coronavirus is affecting lives in every state," said ELITechGroup CEO, Christoph Gauer. "Hospitals and labs need access to reliable COVID-19 test kits, and we are here to support the medical professionals on the front lines working to prevent the spread of COVID-19."

To date, ELITechGroup has delivered more than 700,000 COVID-19 CE-IVD tests worldwide that have proven effective in accurately detecting the infection. ELITechGroup MDx is the exclusive distributor of the test kits to certain markets across the United States.

"We are determined to fight COVID-19 and the alarming infection rates now being seen in the U.S.," said OSANG Healthcare Chairman Dong-Hyun Lee. "We are pleased to partner with ELITechGroup MDx to bring much needed testing kits to U.S. shores."

To learn more or to order the COVID-19 Detection Kit for your lab or hospital, call 800-453-2725 or email at MDxSales@elitechgroup.com.

For more information about ELITechGroup MDx in the Unites States, please visit ELITechGroup.com/North-America/.

About ELITechGroup MDx LLC:ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.

About OSANG Healthcare:OSANG Healthcare is a manufacturer of IVD (In-Vitro Diagnostics) Medical Devices of multiple fields ranging from Biochemistry, Immunoassay, and Molecular Diagnostics distributing globally to 100+ countries for over 23 years. By utilizing our in house innovation, OSANG Healthcare is dedicated to providing the most accurate, affordable, and real-time results at Point-of-Care (POC).

View original content to download multimedia:http://www.prnewswire.com/news-releases/elitechgroup-mdx-llc-and-osang-healthcare-join-fight-against-covid-19-in-the-united-states-providing-fda-emergency-use-authorization-rapid-detection-test-kits-301043453.html

SOURCE ELITechGroup MDx LLC

Read more:
ELITechGroup MDx LLC and OSANG Healthcare Join Fight Against COVID-19 in the United States Providing FDA Emergency Use Authorization Rapid Detection...

Functional Cooperation of Glycine Synthasereductase and Wood-Ljungdahl Pathways for Autotrophic Growth – Mirage News

A joint research team, affiliated with UNIST has identified a new metabolic pathway, in which microorganisms utilize single carbon (C1) gases (CO and CO2) as a feedstock. The new metabolic pathway is thought to be the most energetically efficient pathway, compared to the existing ones, and thus is expected to be used in a variety of industrial applications that involved the conversion of C1 gas into value-added biochemicals.

Published in the March 13th issue of PNAS (Proceedings of the National Academy of Sciences of the United States of America), this research has been jointly carried out by Professor Donghyuk Kim (School of Energy and Chemical Engineering, UNIST) and Professor Byung-Kwan Cho (Department of Biological Sciences, KAIST), and thus participated by Dr. Yoseb Song (Department of Biological Sciences, KAIST), as the first author.

There are currently six autotrophic CO2 fixation pathways, capable of converting C1 gas into organic compounds and one representative example is the photosynthesis in plants. Among those CO2-fixing metabolic pathways in nature, the linear wood-ljungdahl pathway (WLP) in phylogenetically diverse acetateforming acetogens is known to be the most energetically efficient pathway to fix C1 compounds. In particular, acetogens play an important role in the global carbon cycle, with nearly 1013 kg (100 billion US tons) of acetic acid being formed annually.

However, the growth rate of acetogens is 10 times slower than that of industrial microorganisms, such as E. coli. And this puts a limit on its use as industrial microorganisms for the conversion of C1 gas into useful biochemical products. Accordingly, many studies on a new and more effective CO2 fixation have been carried out.

The research team paid special attention to the growth rate of Clostridium drakei, which was faster than that of the other microorganisms, when accompanied by CO2 absorption. And, through this, they expected they might find clues to enhance the C1 gas conversion efficiency.

Figure 1. Acetyl-CoA production ratio in wild-type and knockout strains.

In this study, using the reconstructed genome-scale metabolic model iSL771 based on the completed genome sequence, transcriptomics, 13C isotope-based metabolite-tracing experiments, biochemical assays, and heterologous expression of the pathway in another acetogen, the research team discovered that the WLP and the glycine synthase pathway are functionally interconnected to fix CO2, subsequently converting CO2 into acetyl-CoA, acetyl-phosphate, and serine.

Moreover, the functional cooperation of the pathways enhances CO2 consumption and cellular growth rates via bypassing reducing power required reactions for cellular metabolism during autotrophic growth of acetogens.

Figure 2. Construction of the genome-scale metabolic network model of C. drakei (iSL771).

With the new CO2-fixing metabolic pathway, we shall overcome limitations in the biosynthesis for the production of high value-added compounds, brought by the slow growth rate of acetogens, says Professor Kim.

This work has been supported by the Intelligent Synthetic Biology Centre of the Global Frontier Project and the C1 Gas Refinery Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT (MSIT) and KAIST Cross-Generation Collaborative Research Group (KAIST Biodesign Engineering Laboratory).

Journal Reference

Yoseb Song, Jin Soo Lee, Jongoh Shin, et al., Functional cooperation of the glycine synthase-reductase and Wood-Ljungdahl pathways for autotrophic growth of Clostridium drakei, PNAS, (2020).

Read the original:
Functional Cooperation of Glycine Synthasereductase and Wood-Ljungdahl Pathways for Autotrophic Growth - Mirage News

How Might Resveratrol and Red Wine’s Antiaging Properties Work? – Wine Spectator

While numerous studies have teased at potential benefits of resveratrol, a polyphenolic compound found in red wine and many plants, scientists are still trying to understand its impact on the human body. In a recent study out of University College London, author Dr. Henry Bayele has found an interesting explanation for its potential as an antiaging substance. Dr. Bayeles team found that resveratrol can mimic the hormone estrogen in the human body to activate antiaging proteins called sirtuins, which may help prevent age-related health problems.

The study, published in Scientific Reports, explores dietary sirtuin-activating compounds (dSTACs), including resveratrol. Sirtuins have become a promising target for researchers interested in slowing the aging process. They are proteins produced by the body that appear to impact metabolism and protect against several conditions including obesity, type 2 diabetes, cancer and cardiovascular and neurodegenerative diseases. Learning what spurs the body to produce sirtuins has been a common goal of longevity-focused scientists over the past two decades.

The interest in sirtuins started in 1999, when it was reported that the proteins activation can extend yeast lifespans by as much as 70 percent. The antiaging action of sirtuins appears to be conserved from yeast to mammals, stated a 2017 study published in Biogerontology. However, the complexity of their function increases with the complexity of the organism.

In the lab, Dr. Bayele and his team treated human liver cells in vitro with different types of compounds and found that resveratrol activated sirtuin signals through estrogen receptors by mimicking the hormone. Although estrogen is commonly defined as a female hormone, men and women both produce it, and it can help protect against the same things sirtuins prevent, such as heart disease.

Results also showed that resveratrol mimics estrogen in low doses, but becomes antiestrogenic in higher concentrations, consequently suppressing sirtuin signals. Excessive intake may in fact be counterproductive because, in high doses, the study found that resveratrol inhibited sirtuin activation of the estrogen receptors, Dr. Bayele told Wine Spectator. Therefore, the low doses of resveratrol found in a regular glass of red wine should be sufficient to activate the sirtuins. Simply put, for red wine or resveratrol to improve healthspan, less is more.

So whats a low dose? Dr. Bayele explains that a regular glass of table wine contains about 0.5 to 1 milligram of resveratrol. Of note, these concentrations are similar to those at which resveratrol behaves like estrogen to induce maximal sirtuin signaling through the estrogen receptors, he said.

Other dSTACs studied were better than resveratrol at activating sirtuins, such as isoliquiritigenin, which is found in licorice. According to Dr. Bayele, resveratrol has attracted the most attention due to its accessibility in red wine, combined with its demonstrable protection against metabolic, cardiovascular and neurodegenerative diseases. It has been shown to increase lifespan in diverse organisms, he writes in the study.

While the research shows promise, the findings have yet to face human trials or long-term studies, and must be better understood before potential treatments can be developed. Dr. Bayele also warns that dSTACs are poorly soluble, and its difficult to determine how much are absorbed in the cell culture. His main takeaway is that wine lovers must also incorporate a healthy diet to improve healthy aging and prevent the onset of metabolic and age-related diseases.

In the case of resveratrol, Dr. Bayele says that when humans consume it, only small amounts are rapidly absorbed, while a large proportion gets metabolized in the small intestine, which complicates the validity of the data. In short, it is still unclear how resveratrol intake would affect sirtuin signaling in vivo, but Dr. Bayele is confident that these dietary compounds are hidden treasures.

While [resveratrols] role in aging/lifespan regulation remains controversial, Dr. Bayele writes, Its contribution to healthspan is not in doubt.

Read the original here:
How Might Resveratrol and Red Wine's Antiaging Properties Work? - Wine Spectator

Covid-19 claims the life of beloved chemistry professor – Chemical & Engineering News

Dennis G. Peters, 82, a beloved chemistry professor at Indiana University, died on April 13 from complications related to COVID-19. He was just days away from celebrating his 83rd birthday. Peters contracted COVID-19 while he was hospitalized for an injury that occurred during spring break. Peters was Herman T. Briscoe Professor of Chemistry at Indiana Universities, and was teaching until his injury occurred.

William F. Carroll Jr., an adjunct professor at Indiana University and a past president of the American Chemical Society, says he was heartbroken to hear the news of Peterss passing. Peters was Carroll's research adviser in graduate school.

What do you say about a man who taught intro chemistry for 57 years, essentially 113 consecutive semesters and more than 15,000 students, Carroll says. What do you say about a guy who wrote or co-wrote 5 textbooks that were successful in selling well over 140,000 copies who then used most of the money from the sales of the books to fund things in the laboratory? If we needed a piece of equipment and we didnt have a grant for it, Dennis would reach into his own pocket.

Carroll says Peters instilled in him a sense of independence and perseverance. Dennis Peters let me fail, and I needed that, Carroll says of his graduate school experience. But he always encouraged me to try again.

Peters earned a BS in chemistry from California Institute of Technology in 1958 and a PhD in analytical chemistry from Harvard University in 1962. He joined the Indiana University faculty in 1962. He was an ACS member for 63 years.

Go here to read the rest:
Covid-19 claims the life of beloved chemistry professor - Chemical & Engineering News

Shawnee Mission East chemistry teacher receives KU Wolfe Teaching Excellence award – Shawnee Mission Post

Shawnee Mission East High School chemistry teacher Steven Appier didnt set out to become a teacher as a substitute teacher, he took over a position while he was taking a break from graduate school. Now, hes receiving an award for his continued impact on students.

Appier received a 2020 Wolfe Teaching Excellence award which honors high school teachers who encouraged and positively influenced students from the University of Kansas. The 25-year Shawnee Mission School District veteran said while the award came as a surprise, it illustrates what he feels is the most rewarding part of teaching: making a difference in a students life.

When a student comes back to you and says you made a difference, Im doing this because of you or this happened as a result of something that you said to me or something that you did for me to recognize that youve had an impact on someones life like that, its hard to beat, Appier said.

KU seniors from any department can nominate a high school teacher with an essay on how that teacher influenced their education, both in high school and beyond, to the Wolfe Teaching Excellence Award Committee. Eleanor Stewart-Jones, a KU senior from Mission majoring in chemistry, said nominating Appier was an easy decision to make.

Stewart-Jones said Appiers Advanced Placement Chemistry 2 class was the first class that truly challenged her, and gave her the study skills and grit she needed to major in chemistry at KU. Shes won multiple research and university awards, and will head to Yale University to pursue a PhD in inorganic chemistry after KU, she said.

But Stewart-Jones said shes not the only one of Appiers students to thrive post-high school, which is why three peers provided Stewart-Jones with anecdotes for her nomination essay.

My experience with Mr. Appier is not unique, Stewart-Jones said. He has had a huge number of students go on to be very successful in the sciences.

The Wolfe Teaching Excellence comes with a $3,000 award to Appier and a $1,000 award to SM East. Awardees are typically recognized at the School of Educations commencement ceremony, but commencement has been postponed due to COVID-19.

Appier will be recognized at a later date, once graduation plans are finalized.

See the rest here:
Shawnee Mission East chemistry teacher receives KU Wolfe Teaching Excellence award - Shawnee Mission Post

Cannabis Science and Technology Announces Partnership with the American Chemical Society’s (ACS) Cannabis Chemistry Subdivision (CANN) – Business Wire

CRANBURY, N.J.--(BUSINESS WIRE)--Cannabis Science and Technology, a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation is proud to announce a partnership with the American Chemical Societys (ACS) Cannabis Chemistry Subdivision (CANN).

The partnership will kick-off with the Spring 2020 CANN Virtual Symposium that will take place May 67 featuring several sessions that CANN had planned for the ACS Spring 2020 National Meeting & Expo scheduled for March 22-26, in Philadelphia, Pennsylvania, which was cancelled due to the COVID-19 global pandemic.

We are honored to be able to partner with CANN and the ACS during this uncertain time to help transition their National Meeting & Expo into an innovative virtual symposium, said Mike Hennessy Jr., president and CEO of MJH Life Sciences, the parent company of Cannabis Science and Technology. As our partnership grows, we look forward to working together with them to further their mission and educating the cannabis community.

Throughout the two-day virtual symposium, cannabis scientists, researchers, and industry experts will deliver more than a dozen talks from on a wide array of topics. A special highlight of the virtual symposium will also include presentations from all the 2020 ElShohly Award winners:

Cannabis Science and Technology (CST) stands as a leading publisher in the field of cannabis science, providing a platform for the dissemination of valuable information to the scientific and cannabis community at large, said Julia Bramante, chair of CANN and lead scientist for the Colorado Department of Public Health and Environment. CANN greatly looks forward to its partnership with CST to continue to drive these initiatives of information sharing.

Cannabis Science and Technology is also excited to be CANNs publishing partner for the ACS Fall 2020 National Meeting & Expo taking place August 1620 in San Francisco, California. The magazine will help CANN create and publish a programming booklet for attendees, available both in person and digitally.

For more information and to register for the free virtual symposium, click here.

About Cannabis Science and TechnologyCannabis Science and Technology is a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation. The magazine is accompanied by an online component and provides relevant information and tutorials for all members of the cannabis industry. Cannabis Science and Technology is a brand of MJH Life Sciences, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

Here is the original post:
Cannabis Science and Technology Announces Partnership with the American Chemical Society's (ACS) Cannabis Chemistry Subdivision (CANN) - Business Wire

‘There’s a void in the world’: Students, staff remember IU professor Dennis Peters – Indiana Daily Student

Chemistry professor Dennis Peters poses for a headshot. Peters died Monday.CORRECTION: A previous version of this caption misstated the day of Peters death. The IDS regrets this error. Courtesy Photo

Despite his small stature, Dennis Peters had a roaring voice that filled lecture halls. He leapt up from chairs in the graduate chemistry advising office and wowed children and adults alike with flashes of colors and bright fires during Magic of Chemistry programs, clad in a colorful lab coat decorated with chemical illustrations, mathematical formulas and equations.

Peters, an IU chemistry professor, died Monday after contracting COVID-19 while being hospitalized for an injury that occurred during spring break. He was 82 and died a few days shy of his birthday, according to the IU Chemistry Departments obituary.

He was born in 1937 in Eagle Rock, California, and graduated from California Institute of Technology with a bachelor's of science and got his doctorate at Harvard University. He has been teaching since 1962, according to the obituary. Peters won a number of local and national awards, such as the Herman T. Briscoe Professorship and Chemical Manufacturers Association National Catalyst Award.

Friends and colleagues alike said though he never had kids, his family was the graduate students he advised and colleagues he adored.

IU graduate student Amir Hosseini hasnt seen his family in five years. Hosseini said Peters, his graduate adviser, helped fill that void and became like his family in the United States.

You dont need to be family by blood to love someone, he said.

Hosseini said his biggest regret is that he cant tell Peters how much he meant to him.

I wish I couldve told him how much he meant to me, as a supervisor, as a family member, he said.

Chemistry graduate program coordinator Dalane Anderson said Peters would frequently organize Wine Wednesdays with the graduate students and invite office staff, where everyone would nurse a glass of wine while talking about their personal lives. She said Peters made the office come alive, joking about trips to Hawaii and his love of chemistry.

He has the sweetest spirit about himself, Anderson said.

Michael Samide, one of Peters past graduate students and a professor at Butler University, said he credits Peters for his teaching style and said the way he engages with students is shaped by his former adviser. He recalled Peters would never criticize students if they needed help doing research and would help undergraduate and graduate students alike. He would take students out to dinner to celebrate milestones in their careers and frequently had them over to his house for meals.

The experiments Peters would put on for different schools to entice children with science were always impressive and chaotic, Samide said. He said a fan favorite was color-changing chemical solutions which would change color to the tune of the Lone Ranger theme song. Another involved creating a fire that spread across the lab table Peters worked at, eliciting gasps from the audience.

Ana CoutoPetro, one of Peters graduate students at IU, said he made her more confident in her work. English isnt her native language, so she delivered drafts of papers and presentations in installments. She said he truly enjoyed helping her.

His caring for others, both personally and professionally, was something special, CoutoPetro said. The world is missing someone this week.

Peters would always crack jokes with his students and help them prepare to defend their research in front of the panel, CoutoPetro said. If students needed assistance, his office was always open, and he would drop whatever he was doing to listen.

Lee Klein, another graduate student who worked under Peters and completed his doctorate in 2001, said he remembers the professors craftsmanship with words. Peters would tear papers and drafts apart, rebuilding them and making the writing better. However, he never made students feel small and always invested time into them, Klein said.

A common way Peters would check in with students was through IU sports. He frequently took students to football and basketball games, cheering on the home team and bonding with his graduate pupils.

He was up out of his chair and shouting wildly and cheering them on, Klein said. He turned into a different person. He really got into it.

Ben Gerroll, part of Peters graduate advising group, said the professor was like a father to him. He said the worst thing one of his students could hear was that Peters was disappointed in them and Peters had the perfect balance of hands-off management, yet nurturing and encouraging of all research ideas or topics.

Theres a void in the world now that Im not sure can be filled, he said

Many of Peters' current and former students and colleagues agreed he would be someone the world couldnt replace.

A light as bright as his doesnt shine without lighting others around him, Gerroll said. Theres just so many sides to this magnificent man. We could talk for days, and we wouldnt be able to encompass a small amount of who he is and what he was."

Peters is survived by his nephew Ruben Portugues, who lives in Germany, and by his niece Iliana Portugues who lives in the United Kingdom.

Like what you're reading? Support independent, award-winning college journalism on this site. Donate here.

Students who expose themselves on Zoom calls risk suspension or expulsion.

The move-out period was extended to comply with stay-at-home order.

He has been self-quarantining since his wife tested positive for the virus April 9.

See the original post:
'There's a void in the world': Students, staff remember IU professor Dennis Peters - Indiana Daily Student

Coronavirus trials need to be flexible | Opinion – Chemistry World

This is an important time for clinical trials. Researchers and hospitals are rushing to determine the effectiveness of treatments and vaccines for Covid-19. At the same time, many trials on other medicines are being stopped, suspended, or transferred to remote systems (with medicines and monitoring equipment delivered at home combined with digital consultation).

And while we have begun to see (sometimes confusing) results from a gaggle of preliminary studies looking to evaluate existing or experimental drugs against Covid-19, the picture will only become clear with large scale, high powered efforts such as the Solidarity trial being coordinated by the World Health Organization (WHO).

As Derek Lowe points out in his latest column, those trials will take time to reach a level of evidence sufficient to justify administering a vaccine to millions (or even billions) of people worldwide. But its not just the scale of the trials that presents challenges. The trials design needs careful planning to ensure that they dont overburden already-stretched healthcare systems.

While the WHOs Solidarity trial is rigorously testing four of the most promising treatment options, there is also an opportunity to establish trials that are specifically designed to respond to a rapidly evolving emergency such as Covid-19. That means trials that can adapt their protocols as new information and treatment options become available, without adversely affecting the integrity of the data.

On this front there are lessons to be learned from the past, including the recent Ebola outbreak. Adapting trials on-the-hoof makes it easier to wrongly conclude treatments are effective when they arent. And if a treatment does show definite effects, then there needs to be facility for it to be integrated into the baseline care of other patients, on ethical grounds alone. Some of these issues can be broached by adopting design based on Bayesian statistics, and statisticians at the US Food and Drug Administration (among many others) have put in significant effort to develop guidance for designing trials in this way.

Its also important that the results of these trials are made available quickly, and in open and transparent ways. This will help avoid issues that were seen with Roches influenza drug Tamiflu (oseltamivir). The company is accused of withholding data showing the drug to be less effective than originally claimed, which led various countries to stockpile the drug and prescribe it more widely than perhaps was justified during outbreaks of more virulent flu strains.

These are significant challenges, especially with the time and resource constraints of a pandemic. But, with sufficient cooperation, I believe it can be done.

Visit link:
Coronavirus trials need to be flexible | Opinion - Chemistry World

Nam Ji Hyun, Lee Joon Hyuk, And More Have Brilliant Chemistry On The Set Of 365: Repeat The Year – soompi

MBCs Monday-Tuesday drama 365: Repeat the Year has released new behind-the-scenes stills of the actors hard at work!

365: Repeat the Yeartells the story of a mystery survival game in which people go one year back in time to make their lives perfect, but find themselves trapped in an even more mysterious course of events. The drama is receiving a lot of attention for its thrilling plot and unexpected twists.

It is not an exaggeration to say that the driving force behind the dramais theactors passionate performances and positive energy. In fact, the viewers are witnesses to their wonderful teamwork and bright spirits. The new stills capture the actors genuine comradeship, friendly atmosphere of the drama set, and the actors passion regardless of time and place.

The mood between when the camera is on versus when its off is completely different. The drama showcases a meticulous psychological warfare between the characters with Kim Ji Soo and Yang Dong Geun playing the antagonists, whereas theset off-camera is full of warm smiles, and the cast and crewinteract in an amiable atmosphere.

On top of that, the stillsshowcase the actorsdoing their best and putting on a passionate performance. Lee Joon Hyuk and Nam Ji Hyun review their scripts and rehearse until shooting begins, while Kim Ji Soo and Yang Dong Geun show amazing concentration. The actors discuss their lines together and also pose for photos every now and then.

The next episodes of 365: Repeat the Year will air on April 20 at 8:55 p.m. KST.

Watch 365: Repeat the Year on Viki:

Watch Now

Source (1)

How does this article make you feel?

Originally posted here:
Nam Ji Hyun, Lee Joon Hyuk, And More Have Brilliant Chemistry On The Set Of 365: Repeat The Year - soompi

Chemical tool developed to examine lipids in living cells – Drug Target Review

A new method has been developed by researchers using chemical tools activated by light to influence lipid concentration in living cells.

So far, it has been difficult for researchers to analyse the functions of lipids in living cells. Now, scientists at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) and the Leibniz Research Institute for Molecular Pharmacology (FMP), both in Germany, have now developed chemical tools that can be activated by light and used to influence lipid concentration in living cells.

According to the researchers, this approach could enable medical doctors to work with biochemists to identify what molecules within a cell actually do.

Every cell can create thousands of different lipids (fats). However, little is known about how this chemical lipid diversity contributes to the transport of messages within the cell. This is mainly due to the lack of methods to quantitatively study lipid function in living cells. An understanding of how lipids work is very important because they control the function of proteins throughout the cell and are involved in bringing important substances into the cell through the cell membrane.

The research groups developed chemical tools to control the concentration of lipids in living cells, which can be activated by light. Milena Schuhmacher, the lead author of the study, explained: Lipids are actually not individual molecular structures, but differ in tiny chemical details. For example, some have longer fatty acid chains and some have slightly shorter ones. Using sophisticated microscopy in living cells and mathematical modelling approaches, we were able to show that the cells are actually able to recognise these tiny changes through special effector proteins and thus possibly use them to transmit information. It was important that we were able to control exactly how much of each individual lipid was involved.

Molecular probes (in blue) for the analysis of lipid messengers [credit: Schuhmacher et al., MPI-CBG].

Andr Nadler, who supervised the study, added: These results indicate the existence of a lipid code that cells use to re-encode information, detected on the outside of the cell, on the inner side of the cell.

The results of the study could enable membrane biophysicists and lipid biochemists to verify their results with quantitative data from living cells, say the researchers.

Andr Nadler concluded: Clinicians could also benefit from our newly developed method. In diseases such as diabetes and high blood pressure, more lipids that act as biomarkers are found in the blood. This can be visualised with a lipid profile. With the help of our method, doctors could now see exactly what the lipids are doing in the body. That was not possible before.

The study was published in the journal PNAS.

See the original post:
Chemical tool developed to examine lipids in living cells - Drug Target Review

Infiniti’s Inventory Management Solution Helped a Chemical Manufacturer to Transform the Supply Chain Model to Combat the Business Impact of COVID-19…

LONDON--(BUSINESS WIRE)--Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on inventory management solution for a chemical company in Canada.

Engagement Overview:

Owing to the COVID-19 outbreak, a chemical company faced difficulties in managing their supply chain operations and meeting their clients demands. Also, they faced challenges in securing logistics capacity, managing demand-supply requirements, and identifying alternative suppliers to meet immediate requirements. As a result, the company witnessed a huge loss in profits. The client, therefore, wanted to build a resilient supply chain model and take immediate end-to-end supply chain actions to combat the business impact of COVID-19.

Other key objectives of the engagement were:

Are you facing supply chain complexities owing to the COVID-19 outbreak? We can help you to build a resilient supply chain for the future. Request a FREE proposal here.

Our Approach:

The experts at Infiniti Research worked closely with the clients production team to analyze the extent of the impact caused by the rapidly spreading COVID-19 pandemic. Also, the experts evaluated supply chain complexities, gained visibility into the clients Tier 1 and Tier 2 suppliers, and identified alternative suppliers in non-impacted regions of the world. Besides, the experts devised a demand-forecast strategy.

Business impact of the inventory management solution for the Canadian chemical industry client

By partnering with Infiniti Research, the client was able to transform the supply chain model, optimize production, and mitigate the risks of supply shortages while balancing cash flows.

By leveraging Infinitis inventory management solution, the client was also able to:

For an in-depth market analysis on how COVID-19 is impacting your industry and data-driven insights to plan your next moves, request more info here.

About Infiniti Research

Established in 2003, Infiniti Research, is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us

Read the original post:
Infiniti's Inventory Management Solution Helped a Chemical Manufacturer to Transform the Supply Chain Model to Combat the Business Impact of COVID-19...

Is Tsaker Chemical Group Limited (HKG:1986) Excessively Paying Its CEO? – Yahoo Finance

Yi Ge has been the CEO of Tsaker Chemical Group Limited (HKG:1986) since 2014. First, this article will compare CEO compensation with compensation at similar sized companies. Next, we'll consider growth that the business demonstrates. And finally - as a second measure of performance - we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO.

Check out our latest analysis for Tsaker Chemical Group

At the time of writing, our data says that Tsaker Chemical Group Limited has a market cap of HK$1.4b, and reported total annual CEO compensation of CN1.5m for the year to December 2018. While we always look at total compensation first, we note that the salary component is less, at CN1.2m. As part of our analysis we looked at companies in the same jurisdiction, with market capitalizations of CN707m to CN2.8b. The median total CEO compensation was CN2.1m.

Next, let's break down remuneration compositions to understand how the industry and company compare with each other. On a sector level, around 63% of total compensation represents salary and 37% is other remuneration. So it seems like there isn't a significant difference between Tsaker Chemical Group and the broader market, in terms of salary allocation in the overall compensation package.

So Yi Ge receives a similar amount to the median CEO pay, amongst the companies we looked at. This doesn't tell us a whole lot on its own, but looking at the performance of the actual business will give us useful context. You can see, below, how CEO compensation at Tsaker Chemical Group has changed over time.

Over the last three years Tsaker Chemical Group Limited has seen earnings per share (EPS) move in a positive direction by an average of 59% per year (using a line of best fit). In the last year, its revenue is up 20%.

Story continues

This demonstrates that the company has been improving recently. A good result. It's a real positive to see this sort of growth in a single year. That suggests a healthy and growing business. Shareholders might be interested in this free visualization of analyst forecasts.

Since shareholders would have lost about 40% over three years, some Tsaker Chemical Group Limited shareholders would surely be feeling negative emotions. So shareholders would probably think the company shouldn't be too generous with CEO compensation.

Yi Ge is paid around the same as most CEOs of similar size companies.

We'd say the company can boast of its EPS growth, but we find the returns over the last three years to be lacking. Considering the improvement in earnings per share, one could argue that the CEO pay is appropriate, albeit not too low. On another note, we've spotted 2 warning signs for Tsaker Chemical Group that investors should look into moving forward.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

Read the original post:
Is Tsaker Chemical Group Limited (HKG:1986) Excessively Paying Its CEO? - Yahoo Finance

Killing Eve’s Sandra Oh speaks about creating her on-screen chemistry with Jodie Comer – digitalspy.com

Killing Eve is back for a third season and after seeing the first episode, fans have been delighted that the drama is just as compelling as ever.

One of the many elements of the show that keeps viewers coming back for more is the twisty relationship between MI6 agent Eve Polastri (Sanda Oh) and assassin Villanelle (Jodie Comer), as they swing from violence to tenderness in their obsession with one another.

And actress Oh says that the main secret to keeping the characters' relationship as interesting as it is, is by maintaining a sense of mystery.

"We really dive into the relationship," she told The Sun. "We both understand there's a lot of mystery between Eve and Villanelle and we play it as such. Usually what happens is, story-wise, Eve and Villanelle are kept apart and at a certain point they crash into each other then have their storyline together."

Related: Why Killing Eve's Jodie Comer admires Villanelle

The actress, who also starred in Grey's Anatomy as Cristina Yang for 10 seasons, described her relationship with her co-star Comer as "profound", saying that they "trust each other when the magic is happening".

And Oh is filled with praise for Comer, saying that she is "blown away" by the Newcastle-born actress' ear for accents.

"Jodie has a remarkable ear. She is so talented," she said. "When you hear what she really sounds like you're blown away."

With the global spread of the COVID-19 coronavirus having shut down production on film and television sets worldwide Oh revealed that she doesn't know when work on a fourth season will be possible.

"We are scheduled to go back to Killing Eve in September, but we don't know," she said. "Our show is international. You can't shoot Africa in Scotland, for example. And we don't know what is going on with Scotland."

Related: Killing Eve season 3 is the "most emotionally rocky" yet

The actress added that although we are living through a very difficult time, she is hopeful that the arrival of new episodes of Killing Eve will serve as a welcome distraction for people.

"For us, globally, this month is very tense," she said. "And the fact that the show is coming earlier and hopefully providing a little respite, a positive distraction and energy for people while they are sheltering inside, I'm really grateful for."

Following the shock twist in the third season's opening episode, Killing Eve star Sean Delaney (who plays Kenny Stowton) has weighed in on a big fan theory about his character's mum, Carolyn Martens (Fiona Shaw).

Killing Eve airs on BBC America in the US and BBC iPlayer in the UK. You'll also be able to watch the opening episode of season three tonight (April 19) at 9.15pm on BBC One.

Killing Eve Season 2 [DVD] [2019]

14.99

Killing Eve - Season 1 [DVD]

12.08

Killing Eve season 1 [Digital Download]

BBC/Sid Gentle ProductionsAmazon

Codename Villanelle (Killing Eve #1) by Luke Jennings

3.00

No Tomorrow (Killing Eve #2) by Luke Jennings

US$122.99

Endgame (Killing Eve #3) by Luke Jennings

13.19

Digital Spy now has a newsletter sign up to get it sent straight to your inbox.

Looking for more TV recommendations and discussion? Head over to our Facebook Group to see new picks every day, and chat with other readers about what they're watching right now.

Continue reading here:
Killing Eve's Sandra Oh speaks about creating her on-screen chemistry with Jodie Comer - digitalspy.com

Our Most Abundant Chemical Is The Future Of Fuel – OilPrice.com

Hydrogen is the renewable fuel that could eliminate the biggest source of demand for fossil fuelsthe transportation industry. It is the star in a script for a hydrogen economy built on electrolysis, the process that yields emission-free hydrogen fuel. And now, this script has come a step closer to reality thanks to a new material.

A team of scientists from Northwestern University said this month they had developed an ultraporous material that can be used for storing hydrogen. Storage is one of the challenges hydrogen needs to overcome before becoming a mainstream fuel, and the NU material may go a long way towards solving this problem.

The problem comes down to the cost and safety of storing hydrogen.

The most abundant chemical element in the universe can be stored either as a compressed gas or as a liquid. Both methods are costly and, more importantly, they carry risks because of the immense pressure of a hydrogen tank due to its high flammability.

To address this problem, the Northwestern University team set out to develop a new material, something called a metal-organic framework, or MOF, that could store a lot more hydrogen than other adsorbent materials much more cheaply, and much more safely, the team said in a news release.

Premium: Irans Plan To Lure The U.S. Into War

What is a MOF? In this case, it is a framework of organic molecules and metal ions that self-assemble into a multidimensional, ultraporous structure. As the lead author of the project, associate professor Omar K. Farha says, envision a set of Tinkertoys in which the metal ions or clusters are the circular or square nodes and the organic molecules are the rods holding the nodes together.

As an illustration of what the material is capable of, the authors report that a sample of one gram has a volume equal to the volume of six M&Ms andwait for ita surface area equal to 1.3 football fields. Thats some surface area right there.

We can store tremendous amounts of hydrogen and methane within the pores of the MOFs and deliver them to the engine of the vehicle at lower pressures than needed for current fuel cell vehicles, Farha says.

That could be one hydrogen economy problem almost solved, which would be a major step in the right direction. There is a lot of promise being heaped on hydrogen: early 2017 saw the launch of the Hydrogen Council, a group involving several leading automakers as well as Shell and Total, seeking ways to make hydrogen more commercially viable. The council allocated $1.4 billion on the development of energy storage and fuel cell project development until 2020, and expressed high hopes for the future.

That may be petty cash compared to any Big Oils investment plan for any given year, but it sent a message that hydrogen is going to feature more in the worlds energy mix. However, it has yet to take over gasoline and diesel, even with the storage problem solved thanks to the new material. For starters, hydrogen is a lot more expensive than gasoline and diesel. So are hydrogen cars compared to gasoline cars. Right now, they are being made more affordable with massive subsidies, but China recently showed the world how much a subsidy bill could swell if you dont plan for the long term when it canceled solar farm subsidies because it could no longer afford them.

Premium: Oil Storage Nears Its Limit

And then there is the cost of production. Not all hydrogen is made equal. In fact, there are three varieties, depending on what source material is used to produce the element. There is grey hydrogen, produced from coal and natural gas, there is blue hydrogen, made from natural gas, and theres green hydrogen, the truly renewable sort, produced via water electrolysis. Currently, the blue version is the cheapest one, but clean energy purists are pushing for more green hydrogen.

According to the Hydrogen Council, the continuous scale-up of hydrogen production and distribution could lead to a 50-percent decline in costs by 2030 for many hydrogen applications, making green hydrogen competitive with other low-carbon alternatives and, in some cases, even conventional options. On the flip side, this would require investments of some $70 billion.

There is also the issue of fueling stations. For now, these are few and very far between. Yet if hydrogen is to become a mainstream fuel, billions would need to be spent on a dense enough network of fueling stations. With hydrogen car sales at a meager 7,500 last year, however, such investment is likely considered a high-risk one, despite the subsidies.

So, it seems that it will yet be a while before the hydrogen economy replaces the old fossil fuel order in the world. But the ultraporous MOF that the researchers from Northwestern developed is not just for hydrogen. The material can also be used to store methane and use it to power vehicles. Maybe at some point, it could be used to deliver methane for other purposes, such as heating and power generation.

By Irina Slav for Oilprice.com

More Top Reads From Oilprice.com:

Go here to read the rest:
Our Most Abundant Chemical Is The Future Of Fuel - OilPrice.com

After the spill: safety standards and metrics – Features – The Chemical Engineer

Ten years after Macondo, US offshore drilling safety improvements remain elusive

IN the wake of the Deepwater Horizon incident at the Macondo well, the US Chemical Safety and Hazard Investigation Board (CSB) issued a series of recommendations to bolster safety. These have yet to be fully implemented. As such, offshore drilling in the US remains an unacceptably hazardous operation.

The CSB is a non-regulatory federal government agency that conducts investigations to determine the causal factors leading to major industrial chemical incidents where the release of a hazardous substance resulted in loss of life, serious injury or substantial property damage. Being apart from the industry and other regulatory agencies affords us the independence to examine incidents from a systems perspective, identifying gaps in safety management systems and regulations broadly, and issue recommendations to prevent their reoccurrence or mitigate their consequences.

The Macondo investigation was a multi-year effort for the CSB, and one of the most challenging experiences in agency history. Our investigation commenced several months post-incident after we received requests from the US Congress to apply the same rigour to this complex incident as the agency had to its investigation of the 23 March 2005 explosions and fire at the BP America refinery in Texas City, TX.

Then followed lengthy litigation against Transocean, the drilling contractor and entity with the most eyewitnesses on the rig, for failure to provide key document and interview subjects. The agency prevailed after four-and-a-half years, during which time the CSBs investigation focussed where it could with the cooperation of other entities. The magnitude of the case, and its technical complexity, challenged an agency with limited resources. Nevertheless, we persisted, ultimately issuing four volumes containing 16 safety recommendations. While many official entities investigated this incident, the CSBs reports cover aspects not addressed by these other bodies, most of whose work had concluded before the final phases of testing of the blowout preventer and the conclusion of litigation revealed new insights.

The CSB issued four volumes and an executive summary on the incident:

Full details can be found here.

The CSBs primary lever for driving safety change is our recommendations, which stem from our investigation findings. It is through our recommendations that we drive safety change and through their adoption that we measure success. When we identify safety gaps whose absence could have prevented the incident or mitigated its consequences, we issue a specific recommendation to a recipient to close the gap so a future incident with a similar fact pattern doesnt occur or isnt as catastrophic. Recommendations are only issued for outstanding gaps made at the time our final report is issued; if safety change was made during our investigation then what might have been a recommendation is no longer needed. This is, of course, a desirable outcome.

Given the length of this investigation, other official reports on the incident, and industry efforts to understand and address known issues, one might have hoped that few CSB recommendations would be needed because the desired safety changes would have been made in the time between the incident and the publication of Volumes 1 and 2 (>4 years post-incident) and Volumes 3 and 4 (6 years post-incident). Yet the CSB identified 16 recommended actions that the Board deemed essential for improving safety that had not yet been taken. They include:

The text of each recommendation can be found here.

After CSB recommendations are published, our staff track them through periodic communication with the recipient to encourage their adoption. Progress toward implementation is assessed by the Board, which then votes to change the status of a recommendation. Ultimately, we drive recipients toward full implementation of the recommendation, but we also measure progress made along the way, and may accept alternative actions if they meet the intended goal. The current status of our recommendations reveals that change continues to come slowly. Ten years after the incident, and 46 years after they were issued, only four CSB recommendations have been closed and of those only one has been closed acceptably. Two have been "Closed Reconsidered/Superseded", meaning the Board retracted the recommendation upon new information or additional analysis. One has been "Closed Unacceptable Action/No Response Received". Most remain "Open Awaiting Response" or "Evaluation/Approval of Response" indicating either that the recipient has not yet communicated their intentions regarding the recommended action, or the Board has not yet evaluated its response.

The one acceptably closed recommendation was to the Sustainability Accounting Standards Board (SASB). The following text is from the Boards Recommendation Status Change Summary:

As a part of its investigation, the US Chemical Safety and Hazard Investigation Board (CSB) analysed the current regulatory oversight of US offshore oil and gas operations. The CSB determined that few specific data points relevant to a companys health, safety, and environmental operations are specifically required for disclosure to shareholders of companies trading in the US under regulations promulgated by the Securities and Exchange Commission (SEC) pursuant to the Securities and Exchange Act of 1933 or 1934, Sarbanes-Oxley, Dodd-Frank, or any other existing financial law or regulation. As the SASB has created health, safety, and emergency management reporting standards for both onshore and offshore operations, the Board voted to issue a recommendation to the SASB.

In June of 2016, SASB began the process of modifying its Oil & Gas Exploration & Production Sustainability Accounting Standard. SASB published the final standard on its website on 8 November 2018, along with an accompanying Basis for Conclusions document that outlines the new standards rationale, supporting analysis, market input and benefits.

The Board voted to change the status of CSB Recommendation No. 2010-10-I-OS-R9 to: Closed Acceptable Alternative Action on 15 April 2019 because while the SASBs new standard for the Oil & Gas Exploration & Production Sector does not add additional leading and lagging indicators to actively monitor major accident safety barriers and the management systems for ensuring their effectiveness, it does require reporting a description of process safety related management systems, including safety barriers, used to identify and mitigate catastrophic and tail-end risks in periodic mandatory filings with the SEC, such as the Form 10-Q, Form S-1, and Form 8-K. The new SASB standard also emphasises and promotes the concept that personal safety metrics are important but separate from process safety performance indicators by requiring them to be reported as separate metrics.

There are also positive signs that other recommendations will be adopted. The clearest comes from the Ocean Energy Safety Institute, to whom the CSB issued a recommendation to:Conduct further study on riser gas unloading scenarios, testing, and modelling and publish a white paper containing technical guidance that communicates findings and makes recommendations for industry safety improvements.

The CSB determined that the Macondo incident progressed from a gas-in-riser event ultimately to an uncontrolled blowout after the crews well control actions and the physical well barriers (eg the blowout preventer and diverter system) were unable to mitigate the hazardous conditions created once hydrocarbons entered the riser and noted that this is a hazardous situation because riser gas migration toward the rig may be nearly undetectable and can rapidly change from a seemingly stable condition to an extremely high flow rate, releasing large amounts of gas on the drilling rig that can ignite and explode. [CSB Macondo Report, Volume 3. Section 1.3, page 35.] Therefore, a recommendation
was made to OESI to study various scenarios and publish technical guidance for industry action.

Recommendation No. 2010-10-I-OS-10 to the OESI was made an Open Acceptable Response or Alternative Response by the Board on 29 January 2020 as its ongoing research work on studying riser gas unloading scenarios, testing. Modelling is actively underway and it anticipates publishing a white paper containing technical guidance that communicates findings and makes recommendations for industry safety improvements, in 2021.

The Board also remains optimistic about the eventual closure of 2010-10-I-OS-5, which calls for the American Petroleum Institute to revise API RP 75: Recommended Practice for Development of a Safety and Environmental Management Program for Offshore Operations and Facilities to require a specific focus on major accident prevention. API has revised this recommended practice, and the CSB, which participated in its revision and advocated for inclusion of the elements contained in this recommendation, is now evaluating it for potential closure.

Even after a recommendation has been closed unacceptably, the CSB continues to advocate its adoption. Such is the case for recommendation 2010-10-I-OS-7, which calls upon the US Department of the Interior:Drawing upon best available global standards and practices, develop guidance addressing the roles and responsibilities of corporate board of directors and executives for effective major accident prevention. Among other topics, this standard shall provide specific guidance on how boards and executives could best communicate major accident safety risks to their stakeholders, as well as corporate level strategies to effectively manage those risks.

The Bureau of Safety and Environmental Enforcement, responding on behalf DOI, initially disagreed with CSBs assignment of this recommendation to DOI. The conversation continues. In an effort to demonstrate our commitment to the importance and positive impact of our recommendations and based upon BSEEs decision not to implement recommendation 2010-10-I-OS-7, the Board committed to developing the recommended guidance itself. As a result, our agency recently released the CSB product entitled CSB Best Practice Guidance for Corporate Boards of Directors and Executives in the Offshore Oil and Gas Industry for Major Accident Prevention.

In the aftermath of the explosions and fire came the sinking of the Deepwater Horizon and the largest accidental marine oil spill in history, with environmental and economic costs that reverberate today that threaten the lives and livelihood of workers and communities.

CSB recommendations provide practicable actions that drive safety change.

This article is part of series called Deepwater Horizon: a Decade On. Read the rest of the series here

Excerpt from:
After the spill: safety standards and metrics - Features - The Chemical Engineer

DR. JOHN ROSS: The chemical blob that changed humanity – TheChronicleHerald.ca

DR. JOHN ROSS

It is crazy what an invisible particle made of fat, protein, and RNA despite lacking a nervous system, consciousness or intent has done to humans in a few months. The SARS-2-CoV virus, the virus that causes the CoVID-19 illness, is natures science experiment. It is an inert blob of chemistry. It does not stay alive on surfaces for days when coughed or sneezed out it just falls apart. It is not alive or dead, it just is or is not. It strictly adheres to the laws of nature, including chemistry, physics, biology and mathematics.

The virus found the perfect host to infect. It follows very predictable natural laws. Humans however, prefer beliefs and rules we make up in our heads and share, often force others to believe. Many are ignorant of the natural basic laws that affect us all. In the case of this virus, early alarms in China were suppressed by political hierarchies human created structures. Authoritarian politics does not tolerate the unexpected or embarrassing. Other government leaders, including in the U.S., defended their fragile, highly temperamental economic belief systems, promoting calm and business as usual despite the virus biology and its simple arithmetic exponential spread. People in many countries around the world were supposed to be reassured by our leaders, who could negotiate a better outcome versus that being offered by nature.

But nature does not negotiate. Therefore, in order to survive, we need to change our belief systems.

Viruses and humans

The elegant simplicity of fat, protein, and RNA is like counting using five fingers on one hand. Our human complexity is that of a super-computer, with millions of complex interdependent chemical reactions, specialized organ systems, feedback loops, and a barely understood collaborative relationship with good bacteria on and inside our bodies. Despite the incredible sophistication and complexity, our biology must also follow the laws of nature.

Viruses and humans are driven to make more of each other. Humans make highly complex near-copies of themselves, one or a few at a time, over nine months. Viruses make more of themselves, in millions every few hours. Humans have built in on/off switches. Viruses are like cancers; they have an ON but no OFF switch.

As viruses and humans multiply and spread, they injure their hosts. When SARS-2-CoV infects humans, the immune system triggers a series of responses, in some cases leading to death. When humans and their corporations multiply, they disrupt the planet, affecting all other species.

SARS-2-CoVs near infinity viral copies around the world are a monoculture every one identical. It spreads among us so effectively because we too are a monoculture. Sure, we are different colours and shapes, but we share far more sameness than differences a fact the virus appreciates, but in non-pandemic times, we should appreciate, too. What we have in common far exceeds our superficial differences.

Human belief systems and fantasies

Ultra-sophisticated humans (complex chemistry, physics, biology), in addition to amazing bodies, have amazing brains. Those brains, over millions of years, realized that we are safer and better off staying and working together, as a highly social species, than we are alone. Almost every other species found the same strategy before us schools of fish, flocks of birds, herds of wildebeest, pods of whales, packs of wolves, etc. Sharks are an interesting exception.

The other really interesting brain development was basic storytelling sharing experiences for the benefit of others. Those stories became more and more complex over time, and developed into whole complicated belief systems. The belief systems to this day are shared broadly religions, politics, economies, money, social hierarchies and many others are made up in our minds. They are all software ideas in our heads fantasies that have resulted in hardware creation countries, religious structures, economic mathematical models, currency, partisan politics, to list a few that have, over time become fixed and have been followed relatively unquestioned. They create some desperately desired order and reason in the otherwise frightening random soup of chemical and physical reactions on our planet.

Unlike most other species, we are not obsessed by the fear of predators. Other species are fully occupied by the search for food and avoiding becoming food. Humans, instead, have time to obsess over our made-up beliefs, our fantasies. However, the different beliefs shared by distinct groups creates divisions in our naturally social species. Friction at belief system interfaces result in wars, expansion and contraction of group belief systems, trade barriers, sanctions, etc. That was life as we knew it before late December 2019.

CoVID-19 and a revision of human values and priorities

Then along came the novel SARS-2-CoV. Ultra-basic inert chemical blob versus ultra-sophisticated humans. We all know what has happened in 4.5 months. It is attacking our fragile bodies AND our far more fragile belief systems. It has revealed leaders who prefer fantasies over science and the immutable laws of nature. The economy, revered as our god (fantasy, not nature) is the shared belief system at the root of almost everything. It, like the viral particle on the table top, is rapidly falling apart. It is revealing who the most important people are in our society. It is not the billionaires uber successful in the former economic fantasy who, like sharks, are hiding alone in bunkers and on super yachts around the world, including one in the White House. It is not many of our political leaders, who we refer to as right honourable, your majesty, supreme leader and so on. A few have stepped way up, and many have withered.

The important people in our day-to-day society are basic frontline health-care providers and first responders, care workers in elder-homes, grocery store clerks, supply chain truckers and warehouse workers, local bankers (not the former financial wizards who concoct fantasy investment bubbles), farmers and others. The viral reaction to the rapidly spreading infection has revealed the most fragile underpinnings of our elite created economy the huge number of casual and part-time workers, who over decades were forced to give up security, benefits and the ability to save for retirement or cushion events like this, so corporations could maintain profits. Those workers immediate needs are highlighting another false belief, that government is bad, the unregulated free market good.

We are now making history as the much-maligned federal, state and provincial governments support all people. While the rich can afford to fall and survive, the poor and middle class cannot. Bailing out and propping up large corporations has not, in the past 50 years, resulted in benefits trickling down to workers or security when things tank. Instead, as of today, we are perhaps seeing an unexpected experiment in providing all people with a basic living wage as governments distribute money to those in need. We cannot return to the grossly unequal economic fantasy hierarchy. We need a more inclusive system. While many people are desperate to return to normal, many aspects were very unfair. This is a chance to create a better, more inclusive economy.

Human fantasies vs the ecosystem

What about the ecosystem we share with millions of plants and animals? Yes, the infections and related economic collapse are harming people. But human-made climate change and waste production has declined almost overnight! Country delegates with different belief systems were meeting in Copenhagen, Kyoto, Paris and other places over the years. Stuck in politics and economics, humans were effectively trying to negotiate with nature not really a negotiation because leaders reluctantly decided what was tolerable within their belief system constraints. Nature, however, follows the unyielding laws of physics, chemistry and mathematics. Despite our fantasies, nature decides on the t
iming of earthquakes, floods, continental fires and the reactions to the imbalance of carbon in the atmosphere. This is a magical moment for an actual and metaphorical clearing of the air to align our perceived needs with a sustainable ecosystem.

Conclusion

Nature does not negotiate.

Hubris: excessive pride or self-confidence. The chemical blob SARS-2-CoV has revealed our myths and over confidence, our collective human hubris. Friedrich Nietzsche said, That which does not kill us makes us stronger. Sadly, many humans have died and will die. Hopefully, as we rebuild our strength, we will remember that humans are just one little piece of natures complex puzzle. We cannot gain dominion over her. We share the planet with millions of other species. Humans should learn to work together far more effectively and collaborate with, and not rail against, the laws of nature.

Our history of human ingenuity, as recently displayed in the responses to CoVID-19, is immensely powerful when focused. In non-pandemic times, it is the essence of human activity and production, organized into a trading and sharing economy. The pandemic has also revealed the more important, overarching inclusive and distributive role of strong central government, that can balance fair belief systems and regulations that supports human imagination and creativity.

We should all feel empowered to advocate loudly for a very different new normal that is consistent with our place in nature. We want to return to work, but cannot go back to precarious jobs that undervalue fellow humans. We want a strong economy, but not one that is unjust and exclusive. We need to respect the laws of nature and our complex ecosystem.

A simple lesson from a simple chemical blob.

Dr. John Ross is medical director, Praxes Medical Group, and professor, department of emergency medicine, Dalhousie University. He lives in Halifax.

More:
DR. JOHN ROSS: The chemical blob that changed humanity - TheChronicleHerald.ca

What comic book super heroes and villains tell us about plant and human gene editing and the coronavirus – Genetic Literacy Project

Humanity is currently facing a huge challenge imposed by the coronavirus. Borders are being shut down, planes grounded, and factories closed. At the same time, scientists and public health professionals are working on tests, treatments, and vaccines to soon provide a medical response. Coping with corona might be one of the largest tests humans have faced in the past decades but it wont be the last virus we need to defeat. It is time to embrace bioscience and allow more research and applications of genetic alteration methods.

For the layman, all this technobabble about mutagenesis and genetic engineering is difficult to comprehend and it took me personally a good amount of reading to start grasping what different methods exist and how these can massively improve our quality of life.

Lets first look at the four most common ways to alter the genes of a plant or animal:

This can be even done in grown humans that are alive, which is a blessing for everyone who suffers from genetic disorders. We are able to repair genes in live organisms. Gene editing is also thousands of times more accurate than just bombarding seeds with radiation. Some applied examples are deactivating the gene responsible for generating gluten in wheat: The result is gluten-free wheat. There are several methods that achieve this. One of the most popular ones these days is the so-called CRISPR Cas-9. These scissors are usually reprogrammed bacteria that transmit the new gene information or deactivate defunct or unwanted genes. Many science fiction novels and movies show a future in which we can deactivate genetic defects and cure humans from terrible diseases. Some examples of stories in which CRISPR-like techniques have been used are movies such as GATTACA, Star Treks Wrath of Khan, or the Expanse series in which gene editing plays a crucial role in growing crops in space.

Synthetic biologists have started usingCRISPR to synthetically create partsof the coronavirus in an attempt to launch a vaccine against this lung disease and be able to mass-produce it very quickly. In combination with computer simulations and artificial intelligence, the best design for such a vaccine is calculated on a computer and then synthetically created. This speeds up vaccine development and cuts it from years to merely months. Regulators and approval bodies have shown that in times of crisis they can also rapidly approve new testing and vaccination procedures which usually require years of back and forth with agencies such as the FDA?

CRISPR also allows the search for specific genes, also genes of a virus. This helped researchersto build fast and simple testing proceduresto test patients for corona.

In the long term, gene editing might allow us to increase the immunity of humans by altering our genes and making us more resistant to viruses and bacteria.

While the coronavirus seems to really test our modern society, we also need to be aware that this wont be the last pathogen that has the potential to kill millions. If we are unlucky, corona might mutate quickly and become harder to fight. The next dangerous virus, fungus, or bacteria is probably around the corner. Hence we need to embrace the latest inventions of biotechnology and not block genetic research and the deployment of its findings.

Right now a lot of red tape and even outright bans are standing between lifesaving innovations such as CRISPR and patients around the world. We need to rethink our hostility towards genetic engineering and embrace it. To be frank: We are in a constant struggle to fight newly occurring diseases and need to be able to deploy state of the art human answers to this.

Fred Roeder is a Health Economist from Germany and has worked in healthcare reform in North America, Europe, and several former Soviet Republics. One of his passions is to analyze how disruptive industries and technologies allow consumers more choice at a lower cost. Follow him on Twitter @FredCyrusRoeder

A version of this article was originally published at Consumer Choice Center and has been republished here with permission. The center can be found on Twitter @ConsumerChoiceC

Go here to read the rest:
What comic book super heroes and villains tell us about plant and human gene editing and the coronavirus - Genetic Literacy Project

Wuhan lab says there’s no way coronavirus originated there. Here’s the science. – Livescience.com

An unprecedented amount of research has been focused solely on understanding the novel coronavirus that has taken nearly 150,000 lives across the globe. And while scientists have gotten to know some of the most intimate details of the virus called SARS-CoV-2, one question has evaded any definitive answers Where did the virus come from?

Live Science contacted several experts, and the reality, they said, is that we may never know where this deadly coronavirus originated. Among the theories circulating: That SARS-CoV-2 arose naturally, after passing from bats to a secondary animal and then to humans; that it was deliberately engineered and then accidentally released by humans; or that researchers were studying a naturally-occurring virus that subsequently escaped from a high-security biolab, the Wuhan Institute of Virology (WIV) in China. The head of the lab at WIV, for her part, has emphatically denied any link to the institute.

Just today (April 18), the vice director of WIV Zhiming Yuan CGTN, the Chinese state broadcaster, said "there is no way this virus came from us," NBC News reported. "We have a strict regulatory regime and code of conduct of research, so we are confident."

Furthermore, the notion that SARS-CoV-2 was genetically engineered is pure conspiracy, experts told Live Science, but it's still impossible to rule out the notion that Chinese scientists were studying a naturally-occurring coronavirus that subsequently "escaped" from the lab. To prove any of these theories takes transparent data and information, which is reportedly not happening in China, scientists say. Several experts have said to Live Science and other media outlets have reported that the likeliest scenario is that SARS-CoV-2 is naturally occurring.

Related: 13 coronavirus myths busted by science

"Based on no data, but simply [a] likely scenario is that the virus went from bats to some mammalian species, currently unknown despite speculation, [and] spilled over to humans," said Gerald Keusch, associate director of the Boston University National Emerging Infectious Diseases Laboratories. This spillover event may have happened before the virus found its way into a live animal market, "which then acted as an amplifying setting with many more infections that subsequently spread and the rest is history," Keusch said. "The timeline is fuzzy and I don't think we have real data to say when these things began, in large part because the data are being held back from inspection," Keusch told Live Science.

The SARS-CoV-2 virus is most closely related to coronaviruses found in certain populations of horseshoe bats that live about 1,000 miles (1,600 kilometers) away in Yunnan province, China. The first known outbreak of SARS-CoV-2 in humans occurred in Wuhan and initially was traced to a wet seafood market (which sold live fish and other animals), though some of the earliest cases have no link to that market, according to research published Feb. 15 in the journal The Lancet.

Related: 11 (sometimes) deadly diseases that hopped across species

What's more, despite several proposed candidates, from snakes to pangolins to dogs, researchers have failed to find a clear "intermediate host" an animal that would have served as a springboard for SARS-CoV-2 to jump from bats to humans. And if horseshoe bats were the primary host, how did the bat virus hop from its natural reservoir in a subtropical region to the bustling city of Wuhan hundreds of miles away?

These questions have led some people to look elsewhere in the hunt for the virus's origin, and some have focused on the Wuhan Institute of Virology (WIV).

In 2015, WIV became China's first lab to reach the highest level of bioresearch safety, or BSL-4, meaning the lab could host research on the world's most dangerous pathogens, such as Ebola and Marburg viruses. (SARS-CoV-2 would require a BSL-3 or higher, according to the Centers for Disease Control and Prevention.) Labs like these must follow strict safety guidelines that include filtering air, treating water and waste before they exit, and requiring lab personnel to shower and change their clothes before and after entering the facility, Nature News reported in 2017.

These types of labs do spur concerns among some scientists who worry about the risks involved and the potential impact on public health if anything were to go wrong, Nature News reported.

Related: The 12 deadliest viruses on Earth

WIV was not immune to those concerns. In 2018, after scientist diplomats from the U.S. embassy in Beijing visited the WIV, they were so concerned by the lack of safety and management at the lab that the diplomats sent two official warnings back to the U.S. One of the official cables, obtained by The Washington Post, suggested that the lab's work on bat coronaviruses with the potential for human transmission could risk causing a new SARS-like pandemic, Post columnist Josh Rogin wrote.

"During interactions with scientists at the WIV laboratory, they noted the new lab has a serious shortage of appropriately trained technicians and investigators needed to safely operate this high-containment laboratory," the officials said in their cable dated to Jan. 19, 2018.

When reports of the coronavirus first popped up in China, the U.S. Deputy National Security Advisor Matthew Pottinger reportedly suspected a potential link to China labs. In mid-January, according to a New York Times report, Pottinger asked intelligence agencies like the C.I.A., particularly individuals with expertise on Asia and weapons of mass destruction, to investigate this idea. They came up empty-handed, the Times reported.

Meanwhile, the lab at the center of these speculations had long been sounding the alarm about the risk of the SARS-like coronaviruses they studied to spawn a pandemic.

The head of the lab's bat-coronavirus research, Shi Zhengli, published research on Nov. 30, 2017 in the journal PLOS Pathogens that traced the SARS coronavirus pandemic in 2003 to a single population of horseshoe bats in a remote cave in Yunnan province. The researchers also noted that other SARS-like coronaviruses discovered in that cave used the ACE2 receptor to infect cells and could "replicate efficiently in primary human airway cells," they wrote. (Both SARS and SARS-CoV-2 use the ACE2 receptor as the entry point into cells.)

Zhengli and her colleagues stressed the importance of monitoring and studying the SARS coronaviruses to help prevent another pandemic.

"Thus, we propose that monitoring of SARS-CoV evolution at this and other sites should continue, as well as examination of human behavioral risk for infection and serological surveys of people, to determine if spillover is already occurring at these sites and to design intervention strategies to avoid future disease emergence," they wrote.

Related: 20 of the worst epidemics and pandemics in history

The WIV lab, along with researchers in the U.S. and Switzerland, showed in 2015 the scary-good capability of bat coronaviruses to thrive in human cells. In that paper, which was published in 2015 in the journal Nature Medicine, they described how they had created a chimeric SARS-like virus out of the surface spike protein of a coronavirus found in horseshoe bats, called SHC014, and the backbone of a SARS virus that could be grown in mice. The idea was to look at the potential of coronaviruses circulating in bat populations to infect humans. In a lab dish, the chimeric coronavirus could infect and replicate in primary human airway cells; the virus also was able to infect lung cells in mice.

That study was met with some pushback from researchers who considered the risk of that kind of research to outweigh the benefits. Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris, was one of those scientists. Wain-Hobson emphasized the fact that this chimeric virus "grows remarkably well" in human cells, adding that "If the virus escaped, nobody could predict the trajectory," Nature News reported.

None of this can
show the provenance of SARS-CoV-2.

But scientists can start to rule out an idea that the pandemic-causing coronavirus was engineered in that lab or further created as a bioweapon. Researchers say the overwhelming evidence indicates this is a natural-borne virus that emerged from an animal host, likely a bat, and was not engineered by humans.

Related: 28 devastating infectious diseases

"This origin story is not currently supported at all by the available data," said Adam Lauring, an associate professor of microbiology, immunology and infectious diseases at the University of Michigan Medical School. Lauring pointed to a study published March 17 in the journal Nature Medicine, which provided evidence against the idea that the virus was engineered in a lab.

In that Nature medicine study one of the strongest rebukes of this idea Kristian Andersen, an associate professor of immunology and microbiology at Scripps Research, and his colleagues analyzed the genome sequences of SARS-CoV-2 and coronaviruses in animals. They found that a key part of SARS-CoV-2, the spike protein that the virus uses to attach to ACE2 receptors on the outsides of human cells, would almost certainly have emerged in nature and not as a lab creation.

"This analysis of coronavirus genome sequences from patients and from various animals suggests that the virus likely arose in an animal host and then may have undergone further changes once it transmitted and circulated in people," Lauring told Live Science.

That may rule out deliberate genetic engineering, but what about other scenarios that point to bats as the natural hosts, but WIV as the source of the outbreak?

Although researchers will likely continue to sample and sequence coronaviruses in bats to determine the origin of SARS-CoV-2, "you can't answer this question through genomics alone," said Dr. Alex Greninger, an assistant professor in the Department of Laboratory Medicine and an assistant director of the Clinical Virology Laboratory at the University of Washington Medical Center. That's because it's impossible to definitively tell whether SARS-CoV-2 emerged from a lab or from nature based on genetics alone. For this reason, it's really important to know which coronaviruses were being studied at WIV. "It really comes down to what was in the lab," Greninger told Live Science.

However, Lauring said that based on the Nature Medicine paper, "the SARS-CoV-2 virus has some key differences in specific genes relative to previously identified coronaviruses the ones a laboratory would be working with. This constellation of changes makes it unlikely that it is the result of a laboratory 'escape,'" he said.

As for what viruses were being studied at WIV, Zhengli says she did a thorough investigation. When she first was alerted to the viral outbreak in Wuhan on the night of Dec. 30, 2019, Zhengli immediately put her lab to work sequencing the genomes of SARS-CoV-2 from infected patients and comparing the results with records of coronavirus experiments in her lab. She also looked for any mishandling of viral material used in any experiments, Scientific American reported. She didn't find any match between the viruses her team was working with from bat caves and those found in infected patients. "That really took a load off my mind," she told Scientific American. "I had not slept a wink for days."

At the beginning of February, Zhengli sent a note over WeChat to reassure her friends that there was no link, saying "I swear with my life, [the virus] has nothing to do with the lab," the South China Morning Post reported Feb. 6. Zhengli and another colleague, Peng Zhou, did not reply to a Live Science email requesting comment.

The Wuhan lab does work with the closest known relative of SARS-CoV-2, which is a bat coronavirus called RaTG13, evolutionary virologist Edward Holmes, of the Charles Perkins Center and the Marie Bashir Institute for Infectious Diseases and Biosecurity at the University of Sydney, said in a statement from the Australian Media Center. But, he added, "the level of genome sequence divergence between SARS-CoV-2 and RaTG13 is equivalent to an average of 50 years (and at least 20 years) of evolutionary change." (That means that in the wild, it would take about 50 years for these viruses to evolve to be as different as they are.)

Though no scientists have come forth with even a speck of evidence that humans knowingly manipulated a virus using some sort of genetic engineering, a researcher at Flinders University in South Australia lays out another scenario that involves human intervention. Bat coronaviruses can be cultured in lab dishes with cells that have the human ACE2 receptor; over time, the virus will gain adaptations that let it efficiently bind to those receptors. Along the way, that virus would pick up random genetic mutations that pop up but don't do anything noticeable, said Nikolai Petrovsky, in the College of Medicine and Public Health at Flinders.

"The result of these experiments is a virus that is highly virulent in humans but is sufficiently different that it no longer resembles the original bat virus," Petrovsky said in a statement from the Australian Media Center. "Because the mutations are acquired randomly by selection, there is no signature of a human gene jockey, but this is clearly a virus still created by human intervention."

If that virus infected a staff member and that person then traveled to the nearby seafood market, the virus could have spread from there, he said. Or, he added, an "inappropriate disposal of waste from the facility" could have infected humans directly or from a susceptible intermediary, such as a stray cat.

Though we may never get a definitive answer, at least in the near-term, some say it doesn't matter.

"No matter the origin, evolution in nature and spillover to humans, accidental release from a lab, or deliberate release or genetic manipulation of a pathogen in the lab the way you develop countermeasures is the same," Keusch told Live Science. "Since one can never say 100% for anything, I think we always need to be aware of all possibilities in order to contravene. But the response to develop what is needed to respond, control and eliminate the outbreak remains the same."

Live Science senior writer Rachael Rettner contributed to this report.

Originally published on Live Science.

Read more:
Wuhan lab says there's no way coronavirus originated there. Here's the science. - Livescience.com

Can We Kill the Dreaded Mosquito? – Sierra Magazine

As a major vector for disease, the mosquito has harmed more human beings than just about any other animal, and a changing climate is only boosting those numbers. As the range of disease-carrying species of mosquitoes expands, so does their ability to transmit the parasites and viruses that result in malaria, chikungunya, Zika, yellow fever, West Nile, and dengue fever. In 2018, the continental United States saw a 25 percent increase in severe, neuroinvasive cases of West Nile virus compared with a decade earlier. And over the past three decades, the CDC reports, the worldwide incidence of dengue fever has risen 30-fold.

In cities with well-maintained infrastructure, mosquito populations can be kept in check by minimizing standing water and treating high-risk areas like storm drains. Elsewhere, lowering the risk carried by the creature that the World Health Organization describes as one of the deadliest animals in the world" comes with its own set of complications, including new dangers to the health of humans, other species, and the ecosystems that they depend on. Heres a short guide to the complicated science of mitigating that risk.

Pupae of Aedes mosquitoes at the Insect Pest Control Laboratory located at the FAO/IAEA Agriculture and Biotechnology Laboratories in Seibersdorf near Vienna. | Photo Courtesy of Jesus Reyes/IAEA

Insecticides

In our efforts to preserve health, reduce nuisance, and protect crops and livestock, human beings have a long history of trying to suppress insect populations. The practice of poisoning insects can be traced all the way from 2000 BCE Mesopotamia, when people dusted crops with sulfur, to our modern use of synthetic and natural pesticides. That long history means that mosquitoes have had plenty of opportunity to evolve a resistance to those chemicals, and those chemicalsmost notably DDThave had similar opportunity to accumulate in the environment and threaten other species. In recent years, mosquitoes have developed resistance to four common classes of insecticides. Insecticide-treated nets can reduce the incidence of malaria by nearly half, but (rising rates of resistance notwithstanding) some communities repurpose them as fishing nets, which indiscriminately trap all sizes of fish and pollute the water with insecticide.

Sterilization

In response to the growing global burden of mosquito-borne diseases and the above-mentioned problems with insecticides, the World Health Organization, in partnership with other United Nations branches (including a collaboration with the International Atomic Energy Agency on safety standards and risk assessment frameworks), are turning to the Sterile Insect Technique (SIT), which has been used to combat agricultural pests for more than 60 years in more than 40 countries. In this relatively straightforward method, male insects of a particular species (male insects arent the problemonly the females transmit disease and lay eggs on crops) are bred en masse in a lab, then sterilized via radiation. The sterile males are then released by drone in a community, where theyll matebut fail to reproducewith females, thus reducing the population.

Later this year, field trials will begin to evaluate the effectiveness of SIT against Aedes aegypti mosquitoes and the diseases they transmit. Field trials will take place at preapproved sites in approximately 10 countries.

SITs track record in reducing target insect populations without causing significant harm to the environment make it a promising tool. However, the same radiation that renders the mosquitoes sterile can also make them less healthy, allowing their wild (and fertile) counterparts to outcompete them. Furthermore, the scale production thats necessary to reduce large populations of sterilized mosquitoes is enormous and may be difficult to attain or maintain.

Genetically Self-limited

Another approach to withering mosquito populations is genetic editing. In its latest efforts, UK-based companyOxitec inserts self-limiting dominant lethal genes that pass on to subsequent generations of offspring. The edited gene causes female progeny to die before reaching adulthood, but allows males to survive and pass along the lethal gene to half of their offspring. While it still targets population numbers, this technology addresses one of the feasibility issues associated with SIT. Mosquito populations decline over multiple generations, so one introduction has a more sustained effect, yet as the population falls, the edited gene eventually disappears.

The big gain to be had from reducing populations of target mosquitoeswhether via sterilization or genetic modificationis that they should also suppress transmission of all the viruses that the species carries. There are roughly 3,500 species of mosquito in the world and only a handfulmostly within the Anopholes, Aedes, and Culex generacarry the viruses and parasites that cause diseases such as malaria and dengue. Remove the carriers and its likely that other insects with fill in their niche in the ecosystem.

Animals that consume mosquitoes dont appear to rely exclusively on a single species, or even solely on one type of insect. Decades of success with SIT in agriculture support this idea, says WHO Special Programme for Research and Training in Tropical Diseases researcher Florence Fouque: These predators eat plenty of different insects, so if you suppress the mosquitoes, they eat other insects. For example, in a 20092010 study, researchers examined prey DNA in the fecal matter collected from five species of bats in Australia. Though bats are often touted as heavily dependent on mosquitoes, the scientists found that mosquitoes represented a small proportion of the diet, even for the smallest bats, and that the bats were consuming a wide variety of species of mosquito beyond those that carry malaria.

The Replacement Strategy

At Colorado State Universitys Arthropod-borne and Infectious Diseases Laboratory, Kenneth Olson is working to replace the most disease-carrying mosquitoes instead of eliminating them. For roughly 15 years, he has been developing genetically modified mosquitoes that he hopes will one day replace wild type Aedes aegypti in particular environments. We (and others) have developed transgenic Aedes aegypti that are highly resistant to dengue and Zika viruses, at least in the laboratory, says Olson. The goal of this and similar gene drive projects is to eventually introduce these (male) mosquitoes into a natural environment, where they will breed with wild females and spread the gene that provides disease resistance into the unmodified population. The advantage of a replacement strategy is that we wouldnt eliminate Aedes aegyptiif that bothers peoplebut instead replace the population with mosquitoes that have a virus-resistant phenotype, Olson explains.

Gene editings proponents argue its still effective and less destructive to beneficial insects and other species than the most common alternative: insecticides. Insecticides as a basis of vector control, they are bad for the environment and may affect beneficial insect populations. Further, insecticide treatments can be expensive, and mosquitoes are evolving resistance, Olson says.

But gene drives also have their detractors. Once engineered mosquitoes are removed from the closed conditions of a lab, additional uncontrolled mutations may occur. And, in fact, while field trials of Oxitecs first generation of Friendly Aedes aegypti did demonstrate a substantial reduction in the local mosquito population, they also found a surprise. Reporting on an independent study, Kelly Servick wrote for Science magazine that between 5 and 60 percent of the insects collected in the months after the trial had some DNA from the Oxitec strain in their genome. Though lab studies indicated that about 3 percent of the engineered mosquitoes offspring would survive, field trials demonstrated that they could reproduce and pass pieces of their genomes to subsequent generations. While none of the modified genes were passed on, thi
s does support concerns about our ability to anticipate how things will play out in the natural environment.

Which is, arguably, the very point of the multiphased approach. Before field trials even begin, researchers must demonstrate success for generations in the labone line of mosquitoes has been in Olsons insectary since 2009 (thats 54 generations), and it remains highly resistant to the targeted arbovirus. And once they are launched, they are overseen and carried out in conjunction with host countries, local communities, and in the case of the SIT trials, multiple agencies. In its guidance frameworks for studying the efficacy and safety of various biotechnologies (including genetically manipulated mosquitoes and SIT), the WHO emphasizes the safety of nontarget organisms, responsible community engagement, and more. Gene drive engineering like Olson does is still relatively new and has yet to undergo any field trials, and guidelines for best practices are still being developed. For Olson, a key factor in protecting both the quality of research and the communities most affected by disease will be promoting transparency within the scientific community and with the public.

With the aim of eventually sterilizing and releasing them into the wild, male larvae are reared in laboratory-controlled environments. | Photo Courtesy of Dean Calma/IAEA

Is There a Better Way?

For many, including Olson and Fouque, biotechnology represents a safer and more efficient strategy for combating mosquito-borne diseases when compared with the insecticides that dominate today. Critics of biotechnology and especially genetic engineering are more likely to see it as an uncontrolled ecological experiment with too many unanticipated consequences for the environment and would rather see the energy and funding shift in different directions.

And, in fact, that research is happening as well. Scientists are developing biopesticides made from fungi; studying the efficacy of combating malaria with insecticides and antiparasitics made from nanoparticles (structures ranging from 10 to 100 nm in size) of gold, silver, and other elements; and infecting mosquitoes with a naturally occurring bacteria, Wolbachia, to reduce their lifespan and ability to transmit pathogens. Fish, tadpoles, and other aquatic animals have been shown to drastically reduce populations of mosquito larvae, though the extent to which this ends up affecting transmission remains unclear.

However, much of this work comes with the potential for unanticipated effects. Targeted biopesticides might be safer for other species threatened by conventional pesticides, but don't solve concerns raised above about how this could affect bats, birds, frogs, and other predators. Nanoparticles already occur in nature, but their impact on aquatic environments has been understudied and, as with pesticides, there is the risk of accumulation-related environmental toxicity. Even introducing natural predators to eat mosquitoes can shift ecological balance in unpredictable ways. For example, since mosquitoes represent a small proportion of birds' and bats diets, adding more predators could unintentionally lower populations of moths, beetles, and the other insects those predators consume.

With an array of potential solutions that are as complex as the environments in which they may ultimately be rolled out, no one solution will be perfect. Weve already put our collective thumbs on the scale, introducing mosquito species to new regions, creating conditions in which they flourish, and trying to combat them with sweepingly toxic insecticides. Now its just a question of how to do the least harm.

Note: This article is independent of the Sierra Clubs policy regarding biotechnology, which opposes field release of GMOs unless they are proven safe.

Here is the original post:
Can We Kill the Dreaded Mosquito? - Sierra Magazine